156090-76-5

Downstream Products

• 156090-04-9 2-[2-(N-tert-butoxycarbonylamino)ethyl]-5-(p-toluenesulfonyloxy)-isoquino[8,7,6-cd]indazole-6(2H)-one 
• 156090-03-8 2-<2-(dimethylamino)ethyl>-5-<<(4-methylphenyl)sulfonyl>oxy>indazolo<4,3-gh>isoquinolin-6(2H)-one 
• 156090-02-7 5-(p-toluenesulfonyloxy)-2-methylisoquino[8,7,6-cd]indazole-6(2H)-one 

Relevant academic research and scientific papers

Hetero-annulated indazoles

This invention is directed to heteroannulated indazoles namely to 2,5-disubstituted quinolino-, isoquinolino-, phthalazino-, and quinoxalino- annulated indazole-6(2H)-ones and related mono N-oxides. These compounds have been shown to have antitumor activity.

2-aminoalkyl-5-aminoalkylamino substituted-isoquinoindazole-6(2H)-ones

This invention is directed to 2-aminoalkyl-5-aminoalkylamino substituted isoquino [8,7,6-cd]indazole-6-(2H)-ones and to 2-aminoalkyl-5-aminoalkylamino substituted-isoquino [5,6,7-cd] indazole-6(2H)-ones. These compounds have been shown to have antitumor activity.